Clinical trial · Observational
Diabetes and Palliative Care
Comparison of Glycosuria and Capillary Blood Glucose in Hospitalised Diabetic Patients
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Diabetes prevalence in palliative care is 10-15%. Most hospice patients are treated with insulin. The target glucose level is high in order to decrease the risk of hypoglycemia. Glucose level is usually monitored using capillary blood glucose once to three times daily. The aim of the research is to simplify this pattern of care in end-of-life patients. It will evaluate whether the non invasive measurement of glucose in urine could replace the measurement of capillary blood glucose. The first objective will be to assess the performance of the measurement of glucosuria using urinary dip stix to predict that the blood glucose level is within the target range. Due to the high glucose target, hyperglycemia is extremely frequent. However, symptoms of hyperglycemia are unfrequently reported. They may be unspecific and/or masked in end-of-life patients due to terminal disease and medication. The second objective of the study will be to define symptoms of hyperglycemia in these patients.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Diabetes | — | UNRESOLVED | — |
| End-of-life | — | UNRESOLVED | — |
| Terminal Cancer | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| diagnosis | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Predictive performance of glycosuria measured on urine collected between 10 am and 16 am on the blood glucose level at 6 pm
- timeFrame
- over 12 days
- description
- Glycosuria will be assessed using Ketodiabur 5000 urinary dip stix. The results are semi-quantitative with 8 levels of glycosuria ranging from 0% to 2% (weight/volume). Capillary blood glucose level will be assessed using a glucose meter based on glucose oxydase.
Secondary outcomes (3)
- measure
- Relation between glycemia and glycosuria at different time points over 24 hours.
- timeFrame
- over 12 days
- description
- Glycemia and glycosuria will be assessed as described above.
- measure
- Intensity of pain caused by finger pricking
- timeFrame
- 12 days
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * diabetic patients * hospitalised in a palliative care unit * terminally ill with cancer * with blood glucose measurement at least twice daily over 5 days * agreeing to participate in the study Exclusion Criteria: * patient unable to communicate, to understand information about the study or to decline participation in the study
References
Publications (0)
Data not yet available